Rob Garver

Rob Garver is an accomplished medical professional with extensive experience in critical care and pulmonary medicine. Currently serving as the Chief Executive Officer of SEC Clinical Research since April 2016, Rob transitioned from a Pulmonary/Critical Care Medicine Physician role at SEC Lung, where involvement continued until December 2023. Rob aims to maintain clinical skills through part-time outpatient pulmonary work following the decision to focus full-time on SEC Clinical Research. Educational credentials include a Doctor of Medicine degree from The Johns Hopkins University School of Medicine, along with ABIM certifications in Critical Care Medicine and Pulmonary Disease from UAB Marnix E. Heersink School of Medicine and the National Heart Lung and Blood Institute, respectively.